French M T, Dunlap L J, Galinis D N, Rachal J V, Zarkin G A
University of Miami School of Medicine, Florida 33136, USA.
J Public Health Policy. 1996;17(2):181-203.
In 1992, the United States spent $820 billion on health care. For the same year, an estimated 15 percent of the U.S. population, approximately 43 million people, were uninsured. As health care costs continue to rise, the number of people able to afford coverage continues to decline. Given these statistics, it is not surprising that concern over health care reform is at the forefront of government policy. Over the past few years, policymakers have faced the challenge of creating a more cost-efficient, universal health care system. Many of the proposed reforms rely heavily on managed care practices and treatment limits to help control costs. The impact of managed care is already apparent in primary health care where private insurers have been using it for years (e.g., HMOs, PPOs). However, its full impact on substance abuse treatment services remains unknown. In this paper, we present the perceptions, opinions, and experiences of eleven drug treatment programs regarding the actual or anticipated effects of managed care and health care reforms on the delivery, financing, and costs of substance abuse treatment. We also present an analysis of these programs' current costs and financing. We believe that the information presented in this paper provides timely insights into the substance abuse treatment system; these insights should assist policymakers in developing optimal health care reform policies.
1992年,美国在医疗保健方面支出了8200亿美元。同年,估计有15%的美国人口,即约4300万人没有医疗保险。随着医疗保健成本持续上升,有能力负担保险的人数持续减少。鉴于这些统计数据,对医疗保健改革的担忧成为政府政策的首要关注点也就不足为奇了。在过去几年里,政策制定者面临着创建一个更具成本效益的全民医疗保健系统的挑战。许多提议的改革严重依赖管理式医疗实践和治疗限制来帮助控制成本。管理式医疗的影响在初级医疗保健中已经很明显,私人保险公司多年来一直在使用它(例如健康维护组织、优先提供者组织)。然而,其对药物滥用治疗服务的全面影响仍然未知。在本文中,我们呈现了11个药物治疗项目对管理式医疗和医疗保健改革在药物滥用治疗的提供、融资和成本方面的实际或预期影响的看法、意见和经验。我们还对这些项目的当前成本和融资进行了分析。我们相信本文所提供的信息能及时洞察药物滥用治疗系统;这些洞察应有助于政策制定者制定最佳的医疗保健改革政策。